On July 8, 2013, Michael Iseman resigned as a member of the Board of Directors of Omni Bio Pharmaceutical, Inc. Iseman is resigning for personal reasons and is not resigning because of a disagreement with the company or on any matter relating to its operations, policies or practices.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | +66.67% | +233.33% |
2016 | Omni Bio Pharmaceutical, Inc. cancelled the transaction announced on March 16, 2015 | CI |
2015 | Omni Bio Pharmaceutical, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+233.33% | 50.06K | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.25% | 21.83B | |
-10.42% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- OMBP Stock
- News Omni Bio Pharmaceutical, Inc.
- Omni Bio Pharmaceutical, Inc. Announces Resignation of Michael Iseman as Member of the Board of Directors